Farmak International participated in the international pharmaceutical exhibition CPHI Milan 2026, where, over the course of three days, it showcased its developments in the field of complex generics and injectable products.
At CPHI Milan 2026, the Farmak International team held a series of meetings with existing and potential partners from various countries. At the company’s booth—which focused on the category of finished dosage forms—discussions centered on new projects, opportunities to expand the product portfolio, and avenues for collaboration in international markets.
Farmak International’s focus at the exhibition included:
• Long-acting injectable products
• Peptides
• Hormonal depot formulations
• Contrast agents for CT and MRI
• Treatments for iron deficiency
• Advanced dosage forms and drug delivery systems, including pre-filled syringes, vials, pen injectors, and auto-injectors
Colleagues from all regions where the Farmak Group operates participated in the event.
Discussions with partners highlighted several trends of growing importance within the pharmaceutical industry. These include rising demand for complex generics and modern drug delivery systems, stricter requirements for the reliability of development and manufacturing processes, and a need for partnership models tailored to the specific characteristics of individual markets.
These trends align with the areas in which Farmak International is investing as part of its international expansion. Currently, the company’s products are available in over 60 markets worldwide. We continue to expand our product portfolio, develop our internal capabilities, and strengthen partnerships that will drive further growth in the segments of complex generics and advanced drug delivery systems.
The Farmak Group is a global pharmaceutical business founded in Ukraine in 1925. It operates manufacturing facilities in Ukraine and Spain, and maintains subsidiaries and international representative offices in Poland, the Czech Republic, Slovakia, the United Kingdom, the UAE, Vietnam, Switzerland, Mexico, Kazakhstan, Uzbekistan, Kyrgyzstan, and Moldova.
Farmak International is responsible for the global operations of the Farmak Group, the management of international assets, and business development in foreign markets.
